Publications
Modeling monthly migraine-day distributions using longitudinal regression models and linking quality of life to inform cost-effectiveness analysis: A case study of Fremanezumab in Japanese-Korean migraine patientsInsights
Explore the expertise, insights, and perspectives from OPEN Health that help transform complexity into clarity across today’s healthcare landscape.